Does Intermittent Fasting Help Fatty Liver?

The ultrasound was for something else. The report mentions, almost in passing, a “fatty liver.” Your doctor says it’s common, says to lose some weight and cut back on sugar and alcohol, and books a recheck. You leave wondering whether a 16:8 eating window, which a friend swears by, would do the job faster.

The useful question is whether the eating window adds anything to the other changes your doctor recommended. Two trials help separate those effects.

The short version

Intermittent fasting can be one way to reduce liver fat alongside weight loss. In a year-long trial, adding an 8-hour eating window to calorie restriction did not clearly improve liver fat more than the same calorie targets at usual meal times. That does not prove the approaches are equivalent, or that every benefit depends on weight loss: exercise and diet quality also matter. A fasting schedule is an option to discuss with your clinician, especially if you take diabetes medication; it is not a substitute for assessing liver scarring.

What “fatty liver” means now

Doctors increasingly use a new name. MASLD, metabolic dysfunction-associated steatotic liver disease, replaced the older term NAFLD. It describes fat building up in the liver in someone with at least one cardiometabolic risk factor, such as excess weight around the waist, raised blood sugar, high blood pressure or abnormal blood fats, with alcohol intake and other possible causes assessed separately (EASL–EASD–EASO guideline, 2024).

It’s common. The same guideline estimates that more than 30% of adults worldwide now have it. For many people the fat stays just fat. In some it progresses to inflammation (MASH, previously NASH) and then to scarring, or fibrosis, and the risk is higher in people with type 2 diabetes. The guideline names fibrosis stage as the strongest predictor of liver-related death, and its targets ask for the most weight loss to improve it.

Both trials below measured liver fat with an MRI technique that reports what fraction of the liver is fat. That’s a precise measure of steatosis, the first stage. It is not a biopsy, and it says less about inflammation or scarring.

What the trials compared

These two studies asked different questions. Both measured liver fat with MRI and enrolled adults with obesity and fatty liver under the older NAFLD definition. They are selected examples with full methods and results available, not a complete review of every fasting trial.

Does an eating window add to calorie restriction?

TREATY-FLD in Guangzhou assigned 88 adults to the same calorie targets for a year: 1,200–1,500 a day for women and 1,500–1,800 for men (Wei et al., 2023). Forty-five ate only between 8 am and 4 pm; 43 kept their usual meal times. These were study prescriptions, not calorie targets to copy without individual advice.

Liver fat dropped by 6.9 percentage points with the window and 7.9 with usual timing at 12 months. The between-group difference was 1.0 point, with a 95% confidence interval from −1.6 to 3.5. The data therefore allow an advantage in either direction; they do not establish that the approaches are identical. Weight fell by 8.4 kg and 7.8 kg, respectively.

The support was substantial. Participants logged meals and received nutritionist consultations, regular messages and dietary advice. Seventy-four of the 88 completed the year, while the analysis included all randomized participants. Average adherence was about 85% of days in both groups. This was a supported dietary program, not a test of downloading a timer and changing nothing else.

What about fasting with exercise?

A Chicago trial assigned 80 adults to alternate-day fasting, aerobic exercise, both, or neither for three months (Ezpeleta et al., 2023). Its fasting protocol allowed a 600-calorie dinner on alternate days, with food as desired on the other days. The exercise prescription was five supervised sessions a week. It was more intensive than a typical daily eating window.

The combined program reduced liver fat by 5.5 percentage points, compared with 1.3 with exercise alone and 0.2 in the no-intervention group. Those comparisons were statistically significant. Against fasting alone, which reduced liver fat by 2.3 points, the paper reported no statistically significant difference (P = 0.05). Both fasting groups lost roughly 5% of their body weight.

Seventy-four participants completed the study; all 80 were included in the intention-to-treat analysis. Five of the six withdrawals came from the exercise-only group. The result supports the combined program compared with the control conditions, but it does not establish that adding exercise to fasting produced an extra liver-fat benefit in this small trial. It also does not tell us whether alternate-day fasting beats a daily window.

Two trials, different questions

What was fasting
compared with?

Each row compares a fasting arm with another group in the same trial, on MRI-measured liver fat.

Less liver fat in the fasting arm No clear difference detected

1. Wei et al., 2023 (TREATY-FLD)

   China · 88 randomized · 12 months

   8-hour window (8 am–4 pm) with a set calorie target

   Change in liver fat, percentage points

   vs the same calorie target, usual meal times

   No clear difference detected

   −6.9 vs −7.9 points; difference 1.0 (95% CI −1.6 to 3.5)

2. Ezpeleta et al., 2023

   United States · 80 randomized · 3 months

   Alternate-day fasting plus five weekly aerobic sessions

   Change in liver fat, percentage points

   vs no intervention

   Less liver fat in the fasting arm

   −5.5 vs −0.2 points; P < 0.01

   vs exercise alone

   Less liver fat in the fasting arm

   −5.5 vs −1.3 points; P = 0.02

   vs alternate-day fasting alone

   No clear difference detected

   −5.5 vs −2.3 points; P = 0.05 (reported as nonsignificant)

Compare groups within each trial, not across the two studies. “No clear difference” is not proof the approaches are equal.

What the clock can and cannot tell you

TREATY-FLD gives a useful answer to a specific question: with similar calorie restriction and support, the 8-hour window had no clear added benefit for liver fat. It cannot tell us that meal timing never matters, or that every improvement in liver health must come through weight loss. The Chicago study tested a different combination of diet and exercise, so treating the two as interchangeable would miss the point.

The 2024 European guideline describes little evidence that time-restricted eating improves liver fat more than ordinary calorie restriction. That makes the window a possible tool for following a dietary plan. Some people find a clear evening cutoff useful; others do better with regular meals. Our comparison of intermittent fasting and calorie counting explores that practical choice.

A timer does not measure the result. Atomic Fast applies fixed phase labels by elapsed time, including “Fat Burning” from hour 12. Those labels do not measure your liver fat, diagnose a metabolic state or tell you that liver fat has started disappearing. A longer fast is not automatically a better liver treatment.

Weight-loss targets and benefits beyond the scale

The European guideline is specific about how much weight loss helps. For adults with MASLD and overweight, it recommends aiming for a sustained loss of at least 5% of body weight to reduce liver fat, 7–10% to improve inflammation, and at least 10% to improve fibrosis (EASL–EASD–EASO, 2024).

What the guideline aims for

Liver goals scale with
sustained weight loss.

Each step marks one percentage point of weight loss. Filled dots mark the range the guideline links to each goal.

5% or more

Reduce liver fat

7% to 10%

Improve liver inflammation

10% or more

Improve fibrosis (scarring)

1%2%3%4%5%6%7%8%9%10%11%12%

Illustrative arithmetic for someone starting at 90 kg

• 5% is 4.5 kg
• 7–10% is 6.3–9 kg
• 10% is 9 kg

Those figures come mainly from lifestyle studies. They describe goals for sustained weight loss, not guaranteed results or sharp biological cutoffs. The guideline also notes that many people find it difficult to reach and maintain a 5% loss. That is a reason for ongoing support, not for lengthening a fast whenever the scale stalls.

Weight loss is not the only useful change. The same guideline supports exercise reducing liver fat even without significant weight loss, and describes benefits from a Mediterranean-style diet without weight loss. It recommends:

• Diet quality. A Mediterranean-style pattern, less ultra-processed food and no sugar-sweetened drinks.
• Movement. Preferably more than 150 minutes a week of moderate activity, or 75 of vigorous, tailored to what you can do. Our article on combining fasting with exercise explains how the evidence differs across outcomes.
• Alcohol. It recommends discouraging alcohol for anyone with a fatty liver, especially at moderate or higher intake.

How much to trust this

These studies help answer a practical question, with several limits.

• Short follow-up. The two trials ran for three and twelve months. Neither establishes whether fasting prevents cirrhosis, liver cancer or premature death.
• Fat, not scarring. Liver fat improved on imaging. Stiffness scans also improved in TREATY-FLD, but neither study demonstrated improvement in fibrosis using follow-up biopsies.
• No difference isn’t the same as equal. The confidence intervals leave room for an advantage in either direction. In TREATY-FLD, 33% of the window group and 49% of the usual-timing group got liver fat below the 5% threshold, a gap that wasn’t statistically significant but isn’t proof of a tie either.
• Who took part. TREATY-FLD participants averaged 32 years old. The Chicago group averaged 44 and was 81% female, with mostly early-stage disease. Both trials excluded diabetes. Their results cannot establish fasting safety for people taking diabetes medication or those with advanced liver disease.
• Supported programs. Both studies provided counseling; the Chicago trial initially provided fasting-day meals and supervised exercise. Similar results are not guaranteed from an unsupported change at home.

Who should be careful

Fatty liver often travels with type 2 diabetes, and that changes the safety question. If you take insulin or a sulfonylurea, a fasting window can push blood sugar too low, so set up any schedule with your prescriber first (NIDDK: low blood glucose). Do not adjust medication on your own.

People with cirrhosis are a different case altogether. European nutrition guidance for chronic liver disease recommends shortening the overnight fast in cirrhosis, with a breakfast containing protein and a late-evening snack, because long gaps without food can speed up muscle breakdown (EASL, 2019). Time-restricted eating runs the other way. If you’ve been told your liver is scarred, don’t start fasting without your liver specialist.

The usual exclusions also apply: pregnancy, a history of eating disorders, being underweight, and the other groups in our guide to who should skip intermittent fasting.

What to do with this

• Ask what stage you’re at. Fat alone, inflammation and scarring call for different levels of care. A fibrosis score or stiffness scan tells you more than “fatty liver” on a report.
• Pick the pattern you’ll keep. The year-long trial supports both a calorie-restricted eating window and usual meal timing as possible approaches. Discuss which fits your health, meals and daily life.
• Work on food quality and movement too. A window does not replace a balanced eating pattern or activity you can sustain. These can help even when weight changes are small.
• Aim for the guideline’s targets, with your clinician. Five percent sustained is a meaningful first goal. Your doctor can tell you whether you need more.
• Recheck, don’t guess. Follow-up blood tests or imaging show whether your liver is responding. The scale and how you feel can’t tell you.

If you and your clinician choose a fasting window, Atomic Fast’s free timer can track elapsed time. It does not measure liver fat, assess scarring or tell you whether a fast is safe for your liver.

Frequently asked questions

Can intermittent fasting reverse fatty liver? It can reduce liver fat, sometimes substantially, in people with excess weight. In the year-long TREATY-FLD trial, about a third of the time-restricted group got liver fat below the 5% cutoff for fatty liver. The trials show this happening alongside weight loss, and they don’t show reversal of scarring.

Is 16:8 better than calorie counting for a fatty liver? TREATY-FLD did not find a clear extra liver-fat benefit from an 8 am–4 pm window when both groups had the same calorie targets. Its uncertainty leaves room for an advantage either way. Choose with your clinician based on safety and what you can sustain.

How long does it take to see a change in liver fat? The Chicago trial measured a reduction after three months; TREATY-FLD assessed changes at six and twelve months. These are study assessment times, not a promise about when your liver will improve. Your clinician can plan appropriate follow-up.

Does fasting help fatty liver if I don’t lose weight? These two trials cannot establish a liver-fat benefit from fasting independent of weight loss. That does not mean nothing helps unless the scale moves: the European guideline supports exercise and improved diet quality even without significant weight loss.

Is alternate-day fasting better than a daily window? These trials didn’t compare them head to head. The Chicago alternate-day trial produced about 5% weight loss in three months, but it was small, short and run in highly motivated volunteers. Its 600-calorie alternate days and supervised exercise should not be treated as a personal prescription.

Should I fast if I have cirrhosis? Not without your liver specialist. Guidance for cirrhosis recommends shorter overnight fasts with a protein-containing breakfast and a late-evening snack, which is the opposite of a long fasting window.

Sources

Sources checked: October 17, 2026.

Randomized trials reviewed in full

• Wei et al. (2023), Effects of time-restricted eating on nonalcoholic fatty liver disease: the TREATY-FLD randomized clinical trial, JAMA Network Open — 88 adults with obesity and NAFLD; 74 completed twelve months. Methods, imaging outcomes, uncertainty, adherence and adverse-event reporting reviewed. Same calorie targets in both groups; diabetes excluded; single center with intensive dietary support.
• Ezpeleta et al. (2023), Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial, Cell Metabolism — 80 randomized adults, 74 completers, three months. Methods and outcome tables reviewed; comparisons were against the combined fasting-and-exercise arm. Early disease, diabetes excluded, mostly women and uneven dropout. Does not establish long-term clinical benefit.

Guidelines and safety

• EASL–EASD–EASO (2024), Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease — open copy of the joint guideline, also published in the Journal of Hepatology and Diabetologia. Supports the definitions, prevalence, weight-loss targets, diet, exercise and alcohol recommendations, and its statement on time-restricted eating. The targets are not individual prescriptions.

• EASL (2019), Clinical Practice Guidelines on nutrition in chronic liver disease, Journal of Hepatology — supports the advice to shorten fasting periods in cirrhosis. It does not address MASLD without cirrhosis.

• NIDDK, Low blood glucose (hypoglycemia) — supports the risk of fasting while taking insulin or insulin-releasing medicines. Medication changes require individual clinical advice.

Product notes: the free timer and elapsed-time phase labels were checked against Atomic Fast’s current documentation and source code. This was not a runtime test or clinical validation of phase labels.

---

Atomic Fast is a free fasting timer with an optional food log. Download it on the App Store or Google Play.

This article is for general education and isn’t medical advice. If you’re pregnant, managing a health condition, taking medication, have a history of disordered eating, or are considering fasts longer than 24 hours, talk to a healthcare professional first.